{{copyedit|time=2017-12-16T18:58:59+00:00}}
{{medical}}
{{Infobox drug
| IUPAC_name = α-苯基-2-哌啶乙酸甲酯盐酸盐
| CAS_number = 113-45-1
| CAS_number_Ref = {{cascite|changed|??}}
| ATCvet = N06BA04
| drug_name = 盐酸哌甲酯<br/> Methylphenidate
| image      = Methylphenidate-2D-skeletal.svg
| chemical_formula  = C<sub>14</sub>H<sub>19</sub>NO<sub>2</sub>·HCl
| molecular_weight  = = 269.77
| elimination_half-life = 3.5小時
<!--|適應症 = [[注意缺陷多动障碍|注意缺陷多动障碍]]（ADHD, Attention Deficit Hyperactivity Disorder）-->
| tradename         = 专-{注}-达
<!--|商品名／生産商 = ／西安杨森-->
}}

'''专-{注}-达'''、'''專思達'''（英文名：Concerta）是一种[[哌甲酯|哌甲酯]]缓释长效制剂<ref>范洲际、李允武. {{PDFlink|[http://www.pharmacy9h.com/pharmainfo/Letters/%E6%B3%A8%E6%84%8F%E7%BC%BA%E9%99%B7%E5%A4%9A%E5%8A%A8%E9%9A%9C%E7%A2%8D%E7%9A%84%E6%B2%BB%E7%96%97%E8%8D%AF%E7%89%A9%E8%BF%9B%E5%B1%95.pdf 注意缺陷多动障碍的治疗药物进展]|242 KB}}. 上海交通大学医学院附属第九人民医院. 2007.</ref>，用于治疗[[注意缺陷多动障碍|注意缺陷多动障碍]]（ADHD, Attention Deficit Hyperactivity Disorder）。<ref name="FDA 2007">FDA. {{PDFlink|[http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021121s014lbl.pdf CONCERTA(methylphenidate HCl) Extended-release Tablets CII]|167 KB}} 2007</ref>

12歲以下的使用者，專思達的每日最大劑量上限為54毫克；13到17歲的使用者之每日最大劑量上限為72毫克<ref>{{cite web
 |url         = http://epaper.ntuh.gov.tw/health/201209/project_3.html
 |title       = 過動兒與藥物治療
 |website     = 台大醫院
 |access-date = 2018-04-06
 |author      = 江雅暄
}}</ref><ref>{{cite journal | last=Newcorn | first=Jeffrey H | last2=Ivanov | first2=Iliyan  | title=Psychopharmacologic Treatment of Attention-Deficit/Hyperactivity Disorder and Disruptive Behavior Disorders | journal=Pediatric Annals 2007| volume=36 | issue=9 
| date=2007-09-01 | doi=10.3928/0090-4481-20070901-08 | page=564-574 |url=https://www.healio.com/pediatrics/journals/pedann/2007-9-36-9/%7B6bc30397-acb9-418e-bd9d-f8c81b3f92b4%7D/psychopharmacologic-treatment-of-attention-deficithyperactivity-disorder-and-disruptive-behavior-disorders|quote=The labeled daily maximum dose of d,l-MPH is 60 mg, with the exception of
OROS-MPH, which is approved for 54 mg in children and 72 mg in adolescents}}</ref>。

== 药理作用 ==
盐酸哌甲酯是一种[[中枢神经兴奋剂|中枢神经兴奋剂]]，其治疗注意缺陷多动障碍的作用机制尚不清楚。哌甲酯被认为通过阻断突触前神经元对[[去甲肾上腺素|去甲肾上腺素]]和[[多巴胺|多巴胺]]的再摄取，以及增加这些单胺物质释放至外神经元间隙。哌甲酯是外消旋体，右旋异构体比左旋异构体更具药理活性。<ref name="FDA 2007" />

== 参考文献 ==
{{Reflist}}

== 参见 ==
* [[注意缺陷障碍|注意缺陷障碍]]

[[Category:注意力不足過動症的治療|Category:注意力不足過動症的治療]]
[[Category:药物|Category:药物]]